Free Trial

Cerus (CERS) Competitors

$1.78
-0.11 (-5.82%)
(As of 06/7/2024 ET)

CERS vs. TCMD, LUNG, INO, KIDS, ATRI, ANIK, OSUR, UTMD, WST, and ALGN

Should you be buying Cerus stock or one of its competitors? The main competitors of Cerus include Tactile Systems Technology (TCMD), Pulmonx (LUNG), Inovio Pharmaceuticals (INO), OrthoPediatrics (KIDS), Atrion (ATRI), Anika Therapeutics (ANIK), OraSure Technologies (OSUR), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), and Align Technology (ALGN). These companies are all part of the "medical" sector.

Cerus vs.

Tactile Systems Technology (NASDAQ:TCMD) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, community ranking, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

Tactile Systems Technology has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tactile Systems Technology$274.42M1.04$28.51M$1.2010.03
Cerus$156.37M2.10-$37.49M-$0.17-10.47

83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 1.0% of Tactile Systems Technology shares are owned by company insiders. Comparatively, 3.4% of Cerus shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Tactile Systems Technology has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500. Comparatively, Cerus has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.

Tactile Systems Technology has a net margin of 10.19% compared to Tactile Systems Technology's net margin of -19.27%. Cerus' return on equity of 15.88% beat Tactile Systems Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Tactile Systems Technology10.19% 15.88% 10.33%
Cerus -19.27%-58.65%-15.14%

In the previous week, Tactile Systems Technology and Tactile Systems Technology both had 2 articles in the media. Tactile Systems Technology's average media sentiment score of 1.46 beat Cerus' score of 0.01 indicating that Cerus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tactile Systems Technology
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cerus
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cerus received 206 more outperform votes than Tactile Systems Technology when rated by MarketBeat users. Likewise, 72.26% of users gave Cerus an outperform vote while only 69.62% of users gave Tactile Systems Technology an outperform vote.

CompanyUnderperformOutperform
Tactile Systems TechnologyOutperform Votes
362
69.62%
Underperform Votes
158
30.38%
CerusOutperform Votes
568
72.26%
Underperform Votes
218
27.74%

Tactile Systems Technology presently has a consensus target price of $30.00, suggesting a potential upside of 149.38%. Cerus has a consensus target price of $3.83, suggesting a potential upside of 115.36%. Given Cerus' stronger consensus rating and higher possible upside, equities analysts clearly believe Tactile Systems Technology is more favorable than Cerus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tactile Systems Technology
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cerus
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Tactile Systems Technology beats Cerus on 10 of the 17 factors compared between the two stocks.

Get Cerus News Delivered to You Automatically

Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CERS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CERS vs. The Competition

MetricCerusSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$329.10M$3.91B$5.21B$8.17B
Dividend YieldN/A1.79%2.73%4.04%
P/E Ratio-10.479.53119.1214.80
Price / Sales2.1068.802,422.7468.79
Price / CashN/A48.3435.1231.03
Price / Book6.144.314.964.32
Net Income-$37.49M$4.50M$110.41M$216.21M
7 Day Performance-0.56%-1.00%-1.08%-1.44%
1 Month Performance-5.32%-0.39%-0.64%-0.60%
1 Year Performance-29.64%-18.40%2.85%3.53%

Cerus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TCMD
Tactile Systems Technology
3.0911 of 5 stars
$12.73
-1.5%
$30.00
+135.7%
-50.2%$302.47M$274.42M10.61992Analyst Downgrade
LUNG
Pulmonx
2.1451 of 5 stars
$7.25
-0.7%
$16.33
+125.3%
-44.2%$281.45M$68.68M-4.71279Analyst Forecast
News Coverage
Positive News
High Trading Volume
INO
Inovio Pharmaceuticals
3.5203 of 5 stars
$10.13
+3.7%
$70.67
+597.6%
-88.5%$262.47M$830,000.000.00122
KIDS
OrthoPediatrics
3.2587 of 5 stars
$31.58
-4.5%
$45.50
+44.1%
-35.4%$752.55M$148.73M-32.90247Positive News
ATRI
Atrion
2.1102 of 5 stars
$460.25
-0.4%
N/A-20.3%$810.04M$169.33M43.26712Analyst Forecast
ANIK
Anika Therapeutics
2.6026 of 5 stars
$25.65
-0.2%
$30.50
+18.9%
-3.7%$380.39M$166.66M-4.89357
OSUR
OraSure Technologies
4.0424 of 5 stars
$4.73
+0.6%
$6.63
+40.1%
-14.7%$349.83M$405.47M15.77638Positive News
UTMD
Utah Medical Products
2.3388 of 5 stars
$68.29
+1.7%
N/A-32.4%$241.06M$50.22M15.18169Positive News
WST
West Pharmaceutical Services
4.9233 of 5 stars
$331.41
+0.7%
$435.20
+31.3%
-8.7%$24.14B$2.95B43.7210,600Positive News
ALGN
Align Technology
4.8814 of 5 stars
$257.21
+0.3%
$353.00
+37.2%
-15.3%$19.36B$3.86B42.3721,610Analyst Forecast
Positive News

Related Companies and Tools

This page (NASDAQ:CERS) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners